- Rejects the ad
- Prescription-drug service ads from a telemedicine provider that isn't certified
- Testosterone, cypionate, enclomiphene or any drug term as a keyword
- Claims about energy, muscle, libido or performance outcomes
- Risks the account
- Peptides or other unapproved substances anywhere the ad can reach
- Trademark bidding on drug brands
- New accounts or domains opened to get around a disapproval
- Requires
- Google's prescription drug services certification before prescription-drug ads serve; Google decides coverage from the ads, the site and the app
- Consult-led ads that don't name a drug are still judged on the whole site, so certification is the path
- How we run it
- While certification runs, we build the landing pages to the standard Google and LegitScript review against, and run Meta on the lab-first offer, which Meta allows for general telehealth services without authorization.
Google Ads TRT
Google Ads for TRT clinics and telehealth brands
Short answer
As of October 2026, a TRT telehealth brand needs Google's prescription drug services certification, backed by LegitScript in the US, before its prescription-drug ads serve. Google decides who that covers from the ads, the site and the app, so consult-led ads that don't name a drug are still judged on the whole site; certification is the path. Enclomiphene and peptides stay off the account even after certification because they are not FDA-approved drugs. MedScale Health runs TRT telehealth on Google in that order: certification first, with Meta and the landing pages built while it runs, then clinic, treatment and drug-term campaigns on the certified domain.
Checked against the platform policy pages on October 5, 2026. By Michael Borgia, MedScale Health.
What this means for you
- Certification comes first for a TRT telehealth prescriber. Online TRT clinic and testosterone therapy online are good keywords, but the site behind them is what Google judges.
- Certification is two applications in sequence: LegitScript first, Google second. Budget weeks, not days, and run Meta while it moves.
- Enclomiphene, hCG for TRT and peptides are unapproved-pharmaceutical terms on Google. They cannot be advertised with or without certification.
- Testosterone is a controlled substance, so landing pages state the prescribing and telemedicine requirements plainly. Google and LegitScript both read for that.
- The conversion is labs ordered or intake completed in a served state, then a prescriber visit. Clicks on drug terms from price-shoppers are excluded by negatives.
Policy reality
What each platform allows for TRT and men's health telehealth.
Positions are read from each platform's own policy pages, with the source linked on every row and the date we last checked it. Where a row names a certification it is LegitScript unless the row says Google. LegitScript is the third-party certification Meta and Google require before a pharmacy or telehealth provider can promote prescription drugs.
Checked 2026-10-05How the platforms compare
- Rejects the ad
- Presenting compounded testosterone or enclomiphene as FDA-approved
- Outcome claims
- Risks the account
- Losing LegitScript certification, which revokes Google's
- Drifting from telehealth positioning to pharmacy positioning after approval
- Requires
- LegitScript Healthcare Merchant Certification for the telemedicine provider and its domain, then Google's Healthcare and medicines certification filed for prescription drug services with the certified domain and customer ID
- How we run it
- Clinic, treatment and testosterone keyword campaigns launch on the certified domain, with the controlled-substance and telemedicine requirements stated on the page and no unapproved products anywhere in the account.
- Rejects the ad
- "Low T?" personal-attribute hooks
- Drug names without certification and authorization
- Shirtless or idealized-body imagery
- Risks the account
- Pharmacy-style landing pages
- Enclomiphene or peptides as products
- Requires
- LegitScript certification and Meta authorization before naming testosterone; clinic-service ads run without it
- How we run it
- The same lab-first, provider-led offer, aimed 18 and over, with medication named on the page rather than in the ad until authorization is active.
What Google's rules say about testosterone telehealth
Two Google policies decide the category. The prescription drug services rule requires online pharmacies and telemedicine providers to be certified before their ads serve, and Google decides who is covered from the content of the ads, the site and the app. The restricted drug terms rule changed on October 29, 2025: in the US, drug terms in ad text and on landing pages no longer need certification, but keyword-targeting them does, and certification is still required for telemedicine providers. For a US TRT telehealth brand that means certification first. Separately, Google's unapproved pharmaceuticals rule blocks enclomiphene and peptides outright, because neither is an FDA-approved drug; certification does not change that. And because testosterone is a controlled substance, Google's reviewers and LegitScript's analysts both look for the prescribing and telemedicine requirements to be stated on the page rather than implied.
While certification runs: pages, Meta and the keyword plan
Certification takes weeks, and the time is not wasted. The landing pages are built to the standard Google and LegitScript both review: program and lab panel first, medication options lower down, controlled-substance and telemedicine requirements stated, medical director named. Meta runs on the lab-first offer, because Meta allows ads that promote telehealth services generally without authorization. The Google keyword plan is built and ready: clinic intent (online TRT clinic, TRT telehealth), treatment intent (testosterone therapy online, men's hormone therapy telehealth), process intent (at-home testosterone test, TRT labs online), state intent where the brand is licensed, and negatives that exclude enclomiphene, peptides and price-comparison terms.
Certification: LegitScript, then Google
LegitScript's Healthcare Merchant Certification is one application per website: $975 to apply and $2,150 a year, with expedited review available for $2,500. Its review examines licensing, prescribing practice for a controlled substance, privacy and marketing claims, and answering its questions quickly is the single biggest factor in how long it takes. Once approved, Google's Healthcare and medicines certification is a separate online application filed with the customer ID and the certified domain. Then the clinic, treatment and testosterone keyword campaigns launch on the certified domain, with landing pages that state the compounding status of any compounded testosterone and the prescriber oversight.
Ad copy and landing pages that clear both reviews
Copy that passes is about the process and the provider: labs, visit, prescription if appropriate, follow-up, price. It avoids second-person claims about the reader's energy or performance, which Google reads as unsubstantiated outcome claims and Meta reads as personal attributes. The landing page leads with the program and the lab panel, explains medication options in a lower section, states the controlled-substance and telemedicine requirements in plain language, names the medical director, and carries the certification seal in the footer once it exists. Enclomiphene and hCG, where the brand offers them, are explained on the page as options discussed with the prescriber, never as products with prices, and peptides are kept off every page an ad can reach. A page built this way is ready for LegitScript's analyst and Google's reviewer without being rebuilt.
Measurement and how MedScale Health runs it
The metrics are cost per qualified lead (intake completed in a state the brand serves), labs ordered, prescriber visits booked, prescriptions issued as reported by the intake platform, and ninety-day retention by campaign. The click ID is carried into the intake platform inside a bridge token and each downstream event is sent back server-side with it attached, so the campaign is credited with the patient and no health detail is sent to Google. Week one is the policy read of the account, pages and pixel, with controlled-substance flags listed separately. The LegitScript application starts in parallel where the brand doesn't hold it. Week two puts tracking live, and Meta on the lab-first offer launches by Day 14. Google follows once certification clears. If the account is currently suspended for drug-term or unapproved-substance reasons, the Ad Account Rescue diagnoses the flag inside twelve hours and rebuilds and appeals inside seventy-two.
Results from the accounts
Anonymised results from telehealth brands and clinics that run on our tracking. Names are withheld. Results vary by brand, offer and budget.
- Twice the rate to checkout
- A men's telehealth brand ran two routes from its ads in the same weeks. One reached checkout at 2.7%. The other reached it at 1.3%.
- Booking counts Google can bid on
- For a men's health clinic group, the bookings our server-side tracking sent to Google matched the group's own tag within 5% over two weeks: 156 against 164.
From the answers library
Guides for TRT and men's health.
Can You Advertise TRT on Google?
As of October 2026, an in-person TRT clinic can advertise on Google now and name testosterone in US ad text and landing pages without certification, while bidding on testosterone keywords, or running telehealth TRT ads, needs certification first. MedScale Health, a paid ads agency for US telehealth brands and clinics, builds TRT search campaigns on clinic and lab intent first and files certification alongside them. A telemedicine provider needs LegitScript plus Google certification before its ads serve.
Reviewed October 24, 2026
How Do You Advertise TRT on Meta and Google Without Losing the Account?
As of October 2026, TRT telehealth advertises in two layers on Meta: clinic and program positioning (labs, the visit, the provider, the price) runs without certification, and naming testosterone needs LegitScript plus Meta's authorization. MedScale Health, a paid ads agency for US telehealth brands and clinics, runs that Meta clinic layer while the LegitScript and Google filings are pending. Google is one layer: it names telemedicine providers among the businesses that must be certified, so a TRT telehealth brand needs LegitScript and Google's certification before its ads serve.
Reviewed October 24, 2026
What TRT Ad Creative Passes Meta and Google Review?
As of October 2026, TRT creative passes Meta and Google review when it sells the clinic rather than the hormone: a clinician on camera, the steps of the process, a clear price for the visit and labs, and a consultation as the first step. MedScale Health, a paid ads agency for US telehealth brands and clinics, builds TRT creative in sets and pre-checks every ad against both platforms' health rules before it runs. Body before-and-after, second-person "low T" lines and naming testosterone without LegitScript and platform authorization are what fail.
Reviewed October 24, 2026
What Does the DEA Telemedicine Rule Mean for Telehealth Ads in 2026?
As of November 2026, the DEA flexibilities that let practitioners prescribe controlled medications by telemedicine without an in-person visit run through December 31, 2026, under the fourth temporary extension (Federal Register 2025-24123). MedScale Health, a paid ads agency for US telehealth brands and clinics, plans TRT, ADHD and ketamine ads that hold up whichever way DEA rules. DEA's final special registration rule has been under OMB review since August 25, 2026, with final action listed for November 2026, and as of November 9, 2026 nothing newer is published.
Reviewed November 9, 2026
LegitScript and Google Ads: Which Do You Need, and How Do You Apply?
As of November 2026, a US telehealth provider or online pharmacy needs two certifications to advertise prescription drug services on Google, in order: LegitScript (or NABP, for a pharmacy) first, then Google's own healthcare certification. MedScale Health, a paid ads agency for US telehealth brands and clinics, files both in that order and has Google's form ready the day the LegitScript certificate lands. Google's form, Apply for healthcare-related advertising, is filed from the child Google Ads account with its customer ID and the certified domain.
Reviewed November 9, 2026
Can You Advertise ED and Hair Loss Treatment on Google?
As of October 2026, an in-person ED or hair loss clinic can run Google Search ads now and name sildenafil or finasteride in US ad text and landing pages without certification, though bidding on those names needs certification. MedScale Health, a paid ads agency for US telehealth brands and clinics, builds these accounts on condition and treatment intent and adds drug-name keywords only once certified. An online ED or hair loss service that prescribes is a telemedicine provider and needs LegitScript plus Google certification before its ads serve.
Reviewed October 24, 2026
Google Ads for TRT Clinics and Telehealth questions
What buyers ask before they book.
Can a TRT telehealth brand run Google Ads without LegitScript?
Plan on certification first. Google requires telemedicine providers to be certified before prescription-drug ads serve, and it decides who is covered from the ads, the site and the app. Consult-led ads that don't name a drug are still judged on the whole site, so a TRT prescriber running uncertified is exposed. Meta is different: ads that promote the telehealth service generally run without authorization, so Meta carries the launch while certification moves.
Does certification let us advertise enclomiphene?
No. Enclomiphene is not an FDA-approved drug, so it falls under Google's unapproved pharmaceuticals rule regardless of certification, and the same applies to peptides. A brand that offers enclomiphene explains it on the page as an option discussed with the prescriber and never names it in ads, keywords or as a product for sale.
How long does Google certification take for TRT?
LegitScript's review takes weeks and depends on documentation and response speed; expedited review is offered for $2,500 on top of the standard fees. Google's certification is a separate application after LegitScript approval and is not instant either. Plan for a period of Meta-only advertising while both run, rather than an uncertified Google launch.
Why does Google flag our testosterone landing page even though our ads are clean?
Google reviews the landing page as part of the ad. A page that names testosterone with a price and an order button reads as a pharmacy, which pulls every ad pointing at it under the prescription-drug rules. Lead with the program and the labs, move medication options below the fold, state the prescribing requirements, and remove anything that reads as a drug for sale.
How do you attribute a prescription that happens in our intake platform?
The click ID travels into the intake platform inside a bridge token, and the visit and prescription events are sent back server-side with that token attached. Google receives a generic conversion with the click ID and no health detail; the brand's report shows cost per qualified lead through prescriptions issued by campaign and state.
Does an in-person TRT clinic need certification for Google Ads?
Not for clinic keywords. An in-person clinic can bid on TRT clinic near me, testosterone clinic, men's health clinic or hormone clinic plus a city, and in the US it can name testosterone in its ad text and on its landing page without certification. Keyword-targeting testosterone or another drug term needs Google's certification. Once the clinic prescribes online it is a telemedicine provider, and LegitScript and Google certification come before prescription-drug ads serve.
What does the DEA telemedicine rule mean for TRT Google Ads?
Testosterone is a Schedule III controlled substance, and prescribing it by telemedicine without a prior in-person medical evaluation relies on DEA flexibilities that the current extension keeps in effect through December 31, 2026. For ads, that means no copy that promises a prescription or an online-only start, and landing pages that state the prescribing and telemedicine requirements plainly. MedScale builds offers that hold up if the rule changes: labs first, then a provider visit.
How much does Google Ads management for a TRT brand cost?
The fee is set by scope after a free Growth Audit: which platforms, how many offers and states, and how much new creative each month. It runs month to month. Ad spend is separate and paid to Google from your own account, which stays in your name. For a telehealth brand, LegitScript's fees are separate again and paid to LegitScript. The audit returns a written plan for ads, landing pages and tracking, so the scope is clear before you commit.
From the answers library
The answers behind this page.
Can You Advertise TRT on Google?
As of October 2026, an in-person TRT clinic can advertise on Google now and name testosterone in US ad text and landing pages without certification, while bidding on testosterone keywords, or running telehealth TRT ads, needs certification first. MedScale Health, a paid ads agency for US telehealth brands and clinics, builds TRT search campaigns on clinic and lab intent first and files certification alongside them. A telemedicine provider needs LegitScript plus Google certification before its ads serve.
Reviewed October 24, 2026
How Do You Advertise TRT on Meta and Google Without Losing the Account?
As of October 2026, TRT telehealth advertises in two layers on Meta: clinic and program positioning (labs, the visit, the provider, the price) runs without certification, and naming testosterone needs LegitScript plus Meta's authorization. MedScale Health, a paid ads agency for US telehealth brands and clinics, runs that Meta clinic layer while the LegitScript and Google filings are pending. Google is one layer: it names telemedicine providers among the businesses that must be certified, so a TRT telehealth brand needs LegitScript and Google's certification before its ads serve.
Reviewed October 24, 2026
Why Are Your Google Ads Disapproved for Telehealth, and How Do You Fix It?
As of October 2026, Google disapproves telehealth ads for three recurring reasons: the advertiser is not certified to promote telemedicine or prescription medication, the landing page makes claims the policy treats as unsupported, or the campaign promotes a substance Google restricts outright. MedScale Health, a paid ads agency for US telehealth brands and clinics, checks certification status first, because an uncertified account keeps failing review however carefully the creative is written.
Reviewed October 24, 2026
Who Needs LegitScript Certification to Advertise Telemedicine?
As of November 2026, US telemedicine providers need LegitScript certification before Google or Meta will run their prescription-drug advertising, and online pharmacies need it for Meta and LegitScript or NABP for Google. MedScale Health, a paid ads agency for US telehealth brands and clinics, treats certification as a launch dependency, because campaigns planned around an uncertified account will not deliver. Google names LegitScript as the accreditation for US telemedicine providers, and Meta requires active LegitScript certification plus its own authorization to promote a prescription drug.
Reviewed November 9, 2026
Next step
Start with the audit.
We read your live ads, landing pages and tracking against the rules on this page and send back the flags and a written ninety-day plan in five business days. If the account is already restricted, the rescue is the faster door.
Growth audit
See where your growth is leaking.
We audit the ads, the landing pages, the tracking and the compliance posture, then hand you the roadmap. The people writing it have run the same funnel from the inside. You keep it whether or not we work together.
- Reviewed
- Funnel, tracking, and compliance posture
- Discussed
- One 30-minute call with the operator on your account
- Delivered
- A written roadmap within 5 business days